AUG 12, 2026 · PHASE 3 TRIAL
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
ClinicalTrials.gov
This is a Phase 3 trial registration with no results posted; the study is actively recruiting and outcomes have not yet been reported.
Reported
Planned enrollment586
Study phasePhase 3
Primary outcome 1Change from baseline in ADAS-Cog11 at week…